Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS • Currently up 22.60 (+5.41%) in today's trading session

Track congressional stock trades in Vertex Pharmaceuticals Incorporated (VRTX). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Vertex Pharmaceuticals Incorporated is currently trading at $440.61, positioned at 53% of its 52-week range ($362.50 – $510.77). View which politicians have recently bought or sold VRTX and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only

Copy Portfolio Claim Free Asset

Live portfolio tracking

Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price

$440.61

24h Change

+22.60 (+5.41%)

52 Week Range

$362.50—$510.77

View on NASDAQ

Vertex Pharmaceuticals Incorporated Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for VRTX

Select to highlight on chart

Politician

4 transactions

Include Non-Compliant

Compliance: 40%


David J. Taylor	29 Jan 2026	2 Feb 2026	Sale	Stock	$1,001 - $15,000	N/A (Sale Transaction)
David J. Taylor	7 Aug 2025	2 Sept 2025	Purchase	Stock	$1,001 - $15,000	+14.25%
Byron Donalds	20 Mar 2025	14 Apr 2025	Sale	Stock	$1,001 - $15,000	N/A (Sale Transaction)
Byron Donalds	20 Mar 2025	14 Apr 2025	Sale	Stock	$1,001 - $15,000	N/A (Sale Transaction)

Select transactions to view their annotations on the chart

Earnings

Next Report

Q1 2026

4 May

EPS Est.

$4.43

Rev. Est.

$3.1B

Days Until

Recent Quarters

Q4 202512 Feb

EPS$5.03

Miss 1.6%

Q3 20253 Nov

EPS$4.80

Beat 5.0%

Q2 20254 Aug

EPS$4.52

Beat 5.4%

Q1 20255 May

EPS$4.06

Miss 4.5%

Q4 202410 Feb

EPS$3.98

Miss 1.0%

Q3 20244 Nov

EPS$4.38

Beat 5.8%

Q2 20241 Aug

EPS$-12.83

Miss 10.3%

Q1 20246 May

EPS$4.76

Beat 17.2%

Q4 20235 Feb

EPS$4.20

Beat 2.4%

Q3 20236 Nov

EPS$4.08

Beat 2.8%

Q2 20231 Aug

EPS$3.89

Beat 0.3%

Q1 20231 May

EPS$3.05

Beat 1.7%

Q4 20227 Feb

EPS$3.76

Beat 7.1%

Q3 202227 Oct

EPS$4.01

Beat 10.2%

Q2 20224 Aug

EPS$3.60

Beat 3.5%

Q1 20225 May

EPS$3.52

Beat 0.9%

Q4 202126 Jan

EPS$3.37

Beat 2.1%

Q3 20212 Nov

EPS$3.56

Beat 15.6%

Q2 202129 Jul

EPS$3.11

Beat 15.6%

Q1 202129 Apr

EPS$2.98

Beat 10.8%

Q4 20201 Feb

EPS$2.51

Miss 3.1%

Q3 202029 Oct

EPS$2.64

Beat 12.8%

Q2 202030 Jul

EPS$2.61

Beat 26.1%

Q1 202029 Apr

EPS$2.56

Beat 38.4%

Q4 201930 Jan

EPS$1.70

Beat 40.5%

Q3 201930 Oct

EPS$1.23

Beat 7.9%

Q2 201931 Jul

EPS$1.26

Beat 17.8%

Q1 201930 Apr

EPS$1.14

Beat 17.5%

Q4 20185 Feb

EPS$1.30

Beat 23.8%

Q3 201824 Oct

EPS$1.09

Beat 9.0%

Q2 201825 Jul

EPS$0.94

Beat 25.3%

Q1 201826 Apr

EPS$0.76

Beat 20.6%

Q4 201731 Jan

EPS$0.61

Beat 5.2%

Q3 201725 Oct

EPS$0.53

Beat 43.2%

Q2 201726 Jul

EPS$0.39

Beat 11.4%

Q1 201727 Apr

EPS$0.41

Beat 41.4%

Q4 201625 Jan

EPS$0.35

Beat 34.6%

Q3 201625 Oct

EPS$0.16

Miss 15.8%

Q2 201627 Jul

EPS$0.24

Beat 9.1%

Q1 201627 Apr

EPS$0.09

Miss 66.7%

Q4 201527 Jan

EPS$0.17

Beat 21.4%

Q3 201528 Oct

EPS$-0.13

Beat 53.6%

Q2 201529 Jul

EPS$-0.54

Beat 14.3%

Q1 201529 Apr

EPS$-0.62

Beat 17.3%

Q4 201428 Jan

EPS$-0.73

Miss 19.7%

Q3 201428 Oct

EPS$-0.37

Beat 31.5%

Q2 201429 Jul

EPS$-0.61

Beat 20.8%

Q1 20141 May

EPS$-0.65

Beat 7.1%

Q4 201329 Jan

EPS$-0.56

Miss 24.4%

Q3 201329 Oct

EPS$-0.32

Beat 17.9%

Q2 201329 Jul

EPS$-0.03

Beat 85.7%

Q1 201330 Apr

EPS$0.03

Beat 117.7%

Q4 201229 Jan

EPS$0.04

Beat 133.3%

Q3 20121 Nov

EPS$0.13

Miss 23.5%

Q2 201230 Jul

EPS$0.46

Miss 20.7%

Q1 201226 Apr

EPS$0.43

Miss 23.2%

Q4 20112 Feb

EPS$0.74

Beat 5.7%

Q3 201127 Oct

EPS$1.02

Beat 385.7%

Q2 201128 Jul

EPS$-0.85

Beat 11.5%

Q1 20113 May

EPS$-0.91

Beat 16.5%

Q4 20103 Feb

EPS$-0.90

Beat 3.2%

Q3 201025 Oct

EPS$-1.04

Miss 11.8%

Q2 201028 Jul

EPS$-1.00

Miss 19.1%

Q1 201021 Apr

EPS$-0.83

Miss 3.8%

Q4 20094 Feb

EPS$-0.85

Beat 0.0%

Q3 200926 Oct

EPS$-0.84

Miss 2.4%

Q2 20095 Aug

EPS$-0.99

Miss 17.9%

Q1 200916 Apr

EPS$-1.04

Miss 26.8%

Q4 20089 Feb

EPS$-0.96

Miss 3.2%

Q3 200827 Oct

EPS$-0.93

Miss 1.1%

Q2 200831 Jul

EPS$-0.66

Miss 15.8%

Q1 200821 Apr

EPS$-0.72

Miss 10.8%

Q4 200711 Feb

EPS$-0.66

Beat 0.0%

Q3 200729 Oct

EPS$-0.82

Miss 12.3%

Q2 200724 Jul

EPS$-0.91

Miss 31.9%

Q1 200730 Apr

EPS$-0.64

Beat 0.0%

Q4 20061 Feb

EPS$-0.22

Beat 42.1%

Q3 200626 Oct

EPS$-0.46

Beat 4.2%

Q2 200626 Jul

EPS$-0.72

Miss 38.5%

Q1 200625 Apr

EPS$-0.47

Beat 16.1%

Q4 20057 Feb

EPS$-0.38

Miss 65.2%

Q3 200526 Oct

EPS$-0.84

Miss 78.7%

Q2 200527 Jul

EPS$-0.50

Beat 2.0%

Q1 200526 Apr

EPS$-0.56

Beat 0.0%

Q4 20049 Feb

EPS$-0.54

Miss 22.7%

Q3 200425 Oct

EPS$-0.49

Miss 2.1%

Q2 200426 Jul

EPS$-0.56

Miss 9.8%

Q1 200426 Apr

EPS$-0.52

Beat 0.0%

Q4 200311 Feb

EPS$-0.51

Beat 5.6%

Q3 200310 Nov

EPS$-0.58

Miss 18.4%

Q2 200324 Jul

EPS$-0.60

Beat 1.6%

Q1 200324 Apr

EPS$-0.64

Miss 33.3%

Q4 20024 Feb

EPS$-0.40

Beat 0.0%

Q3 20024 Nov

EPS$-0.44

Miss 46.7%

Q2 200218 Jul

EPS$-0.28

Beat 0.0%

Q1 200224 Apr

EPS$-0.29

Miss 3.6%

Q4 20017 Feb

EPS$-0.15

Beat 21.1%

Q3 200124 Oct

EPS$-0.18

Beat 33.3%

Q2 200127 Jul

EPS$-0.16

Beat 38.5%

Q1 200124 Apr

EPS$-0.15

Beat 51.6%

Q4 200022 Feb

EPS$-0.04

Beat 71.4%

Q3 200024 Oct

EPS$-0.46

Miss 109.1%

Q2 200026 Jul

EPS$0.22

Beat 4.8%

Q1 200011 May

EPS$-0.31

Miss 6.9%

Q4 199916 Feb

EPS$0.03

Beat 425.4%

Q3 199927 Oct

EPS$-0.28

Miss 12.0%

Q2 199927 Jul

EPS$-0.21

Miss 10.5%

Q1 199921 Apr

EPS$-0.34

Miss 13.3%

Q4 199825 Feb

EPS$-0.25

Miss 19.1%

Q3 199821 Oct

EPS$-0.04

Beat 55.6%

Q2 199822 Jul

EPS$-0.19

Miss 26.7%

Q1 199822 Apr

EPS$-0.16

Beat 0.0%

Q4 199723 Feb

EPS$-0.13

Beat 13.3%

Q3 199721 Oct

EPS$-0.11

Beat 21.4%

Q2 199722 Jul

EPS$-0.03

Beat 75.0%

Q1 199722 Apr

EPS$-0.13

Beat 13.3%

Q4 199619 Feb

EPS$-0.09

Beat 43.8%

Q3 199623 Oct

EPS$-0.16

Beat 15.8%

Q2 199626 Jul

EPS$-0.21

Miss 16.7%

Q1 199625 Apr

EPS$-0.21

Miss 23.5%

Q4 199522 Feb

EPS$-0.02

Beat 77.8%

Q3 199525 Oct

EPS$-0.20

Miss 25.0%

Q2 199526 Jul

EPS$-0.26

Miss 85.7%

Q1 199527 Apr

EPS$-0.13

Beat 23.5%

Q4 199415 Feb

EPS$-0.15

Beat 11.8%

Q3 199421 Oct

EPS$-0.12

Beat 7.7%

Q2 199421 Jul

EPS$-0.17

Miss 54.5%

Q1 199425 Apr

EPS$-0.11

Beat 8.3%

Q4 199311 Feb

EPS$0.35

Beat 333.3%

Q3 199331 Dec

EPS$0.30

Q2 199322 Jul

EPS$-0.03

Q1 199319 May

EPS$-0.13

Beat 7.1%

Q4 199210 Feb

EPS$-0.11

Miss 266.7%

Q3 199231 Dec

EPS$-0.11

Q1 199230 Jun

EPS$-0.08

Q4 199131 Mar

EPS$-0.07

Q3 199131 Dec

EPS$-0.06

Q3 199131 Dec

EPS$-0.09

Q2 199130 Sept

EPS$-0.07

Q1 199130 Jun

EPS$-0.07

Q3 199031 Dec

EPS$-0.08

Q3 199031 Dec

EPS$-0.08

Q3 199031 Dec

EPS$-0.08

Q3 199031 Dec

EPS$-0.08

1 politician traded within 30 days

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

MCK

McKesson Corporation

$867.40+7.24 (+0.84%)

Healthcare

2 politicians both hold this

Same sector: Healthcare

2 politicians

View Stock

V

Visa Inc.

$299.55+4.03 (+1.36%)

Financial Services

3 politicians hold this stock

3 politicians

View Stock

JPM

JPMorgan Chase & Co.

$284.89+2.05 (+0.72%)

Financial Services

3 politicians hold this stock

3 politicians

View Stock

Vertex Pharmaceuticals Incorporated (VRTX)

Want to automatically copy Pelosi trades?

Vertex Pharmaceuticals Incorporated Price History and Technical Analysis

Congressional Trading Activity for VRTX

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Stock Splits

Split History

Similar Stocks

MCK

V

JPM

Vertex Pharmaceuticals Incorporated (VRTX)

Want to automatically copy Pelosi trades?

Vertex Pharmaceuticals Incorporated Price History and Technical Analysis

Congressional Trading Activity for VRTX

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Stock Splits

Split History

Similar Stocks

MCK

V

JPM

Track VRTX in Congress